Use of a Vibration Tool for Postoperative Pain Control in Distal Radius Fractures
Launched by NORTHWESTERN UNIVERSITY · Apr 6, 2022
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a special vibration tool can help manage pain better after surgery for distal radius fractures, which are breaks in the wrist bone. The researchers want to see if using this tool not only reduces pain but also helps patients use less pain medication during their recovery.
To participate in the study, individuals must be between the ages of 65 and 74 and have had a specific type of surgery called open reduction and internal fixation for their fracture. They should be able to read, write, and understand English and be willing to go through occupational therapy at a specific clinic. However, people who are having certain types of surgeries or those who only need simpler treatments for their fractures cannot join. If someone participates, they can expect to use the vibration tool after their surgery and share their experience to help improve pain management for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a distal radius fracture who have undergone an open reduction and internal fixation using a volar FCR approach with a single volar plate
- • Patients who can read, write, and follow direction in English
- • Willing to undergo occupational therapy at Northwestern Medicine's Hand Surgery clinic
- Exclusion Criteria:
- • Patients undergoing oncologic surgery
- • Patients who undergo simultaneous surgery such as open carpal tunnel
- • Patients who only require closed reduction of distal radius fractures
- • Operative patients that require dorsal plate fixation or separate radial styloid plate fixation
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Jason H Ko, MD, MBA
Principal Investigator
Associate Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials